Home/ Stocks/ ACXP

Acurx Pharmaceuticals, Inc. Common Stock

ACXP XNAS

$4.28 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$12.92M

About Acurx Pharmaceuticals, Inc. Common Stock

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 4 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-7,966,538	$-5.32
FY 2025	$0	$-7,966,538	$-5.32
Q3 2025	$0	$-1,992,790	$-1.23
Q2 2025	$0	$-2,246,279	$-1.89

TickerDaily Coverage

Why Is Acurx Pharmaceuticals, Inc. Common Stock (ACXP) Stock Up 58.6% Today?

Penny Stocks Marcus Rivera · Mar 11, 2026

Acurx Pharmaceuticals (ACXP) ripped 58.6% higher to $4.53 on surging volume as the biodefense...

Why Is Acurx Pharmaceuticals, Inc. Common Stock (ACXP) Stock Up 52.9% Today?

Penny Stocks Marcus Rivera · Mar 10, 2026

Acurx Pharmaceuticals (ACXP) crushed higher Wednesday, gaining 52.9% to close at $2.9361 on massive...

View All Coverage →

Get ACXP Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Acurx Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.